FDA seeks top-to-toe review of Wockhardt manufacturing
December 9, 2013Manufacturing and Production AZ, GMP, Taylor, Wockhardt. fda
Wockhardt has been asked to undertake an assessment of its entire manufacturing processes, according to an FDA warning letter. Sent …
Pfizer cuts manufacturing again with plant closure
December 9, 2013Manufacturing and Production Ireland, Merck, Pfizer, Taylor, facility
A packaging plant in Ireland is the latest to come into the cross-hairs of the people at Pfizer tasked with …
CLL drug achieves ‘unprecedented’ remissions
December 9, 2013Research and Development, Sales and Marketing AbbVie, CML, Genentech, abt-199
AbbVie and Genentech’s investigational oncology drug ABT-199 has performed well in a Phase I trial for blood cancer, according to …
Gilead’s $1,000 per day Hep C drug approved
December 9, 2013Sales and Marketing FDA, Gilead, hepc, sofosbuvir, sovaldi
Gilead’s Sovaldi has gained FDA approval as a potential cure for hepatitis C after the US regulator sped up its …
API imports in the EU: gauging the FMD’s impact
December 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing API, EMA, FMD, Taylor, manufacturing, supply chain
The deaths of dozens of patients as a result of the contaminated heparin incident in 2008 casts a long shadow …
Savara Pharmaceuticals appoints two board members
December 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph McCracken, Pikover, savara
Speciality pharma firm Savara Pharmaceuticals has appointed Dr Joseph McCracken and Yuri Pikover to its board of directors. McCracken has …
EMA in new Iclusig probe
December 9, 2013Sales and Marketing Ariad, EMA, iclusig, leukaemia
Europe’s medicines regulator has begun a new review of Ariad Pharmaceuticals’ leukaemia drug Iclusig, looking in particular at the risk …
GSK launches cancer ‘consortium’
December 6, 2013Research and Development, Sales and Marketing Cancer, GSK, octc, oncology, research
GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …
FleishmanHillard hires senior head from Edelman
December 6, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FleishmanHillard, tolk
Comms and PR global agency FleishmanHillard has appointed Jerry Tolk to be its senior VP, partner and general manager in …
NICE wants more Lemtrada data
December 6, 2013Sales and Marketing Lemtrada, MS, NICE, Sanofi
NICE has said there are ‘still questions to be answered’ over Sanofi’s submission of its multiple sclerosis drug Lemtrada and …
Court annuls EMA data decision
December 5, 2013Medical Communications, Sales and Marketing AbbVie, EMA, Goldacre, InterMune, alltrials, transparency
The European Court of Justice has annulled interim injunctions against the European Medicines Agency issued earlier this year after AbbVie …
New insulin scores for Sanofi
December 5, 2013Research and Development, Sales and Marketing Lantus, Sanofi, diabetes, u300
Sanofi has been cheered after late-stage results from its investigational insulin U300 showed that the product may have advantages over …
British Safety Council appoints new commercial director
December 5, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BSC, richard evens
Not-for-profit organisation The British Safety Council has appointed Richard Evens as its new commercial director. Evens will be responsible for …
Astellas seeks Xtandi extension
December 5, 2013Sales and Marketing Astellas, Cancer, EU, FDA, US, Xtandi
Astellas Pharma and development partner Medivation are seeking to extend the reach of oncology brand Xtandi by conducting a trial …
Pfizer head to be ABPI president
December 4, 2013Medical Communications, Sales and Marketing ABPI, MSD, PPRS, Pfizer, Whitehead, emms, khanna
The UK managing director of Pfizer Jonathan Emms is to replace Deepak Khanna as the ABPI president from April next …
Pfizer expands in Poland
December 4, 2013Sales and Marketing OTC, Pfizer, Poland, polocard, zf polpharma
Pfizer has bought the rights to one of Poland’s biggest OTC brands in a move which sees the US group …
Forest cuts jobs in restructure
December 4, 2013Research and Development, Sales and Marketing Forest Labs, R&D, US, cuts
Forest Laboratories is restructuring and shedding jobs in a bid to save $500 million in costs by the end of …
Prime minister backs GSK in corruption row
December 4, 2013Medical Communications, Sales and Marketing China, GSK, bribery, david cameron
Prime minister David Cameron has defended London-based pharma giant GlaxoSmithKline over its treatment in China during a visit to the …
Just:: Health hires new director from Edelman
December 4, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Just: Health, Just:: Health
Just:: Health Communications has hired Catherine Barnett to strengthen its senior management team from January next year. Barnett is currently …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
